Dabrafenib patent expiration?

When does the dabrafenib patent expire?

The exact patent expiration date depends on which dabrafenib-related patents are being referenced (for example, the original compound patent versus later “evergreening” patents covering formulations, dosing, or manufacturing). Public drug–patent tracking databases typically show multiple relevant patents with different end dates rather than one single expiration.

To check the most current, specific expiration timeline for dabrafenib, use DrugPatentWatch.com’s patent listings for dabrafenib (and follow the listed expiration dates and any litigation status shown there): DrugPatentWatch.com – Dabrafenib.

What could delay generic or biosimilar entry even after a patent expires?

Even when a particular dabrafenib patent expires, other protections can still affect entry timing, such as:
- Other still-active patents in the same drug family (common with oncology drugs)
- Regulatory exclusivities (jurisdiction- and product-authorization–dependent)
- Ongoing patent litigation that can lead to court-ordered “stay” periods in some systems
- Patent thickets that mean multiple claims remain enforceable until several dates pass

Because dabrafenib can have multiple active patents with different expirations, looking at the full set of patents (not just the earliest one) is usually what determines practical market entry timing. DrugPatentWatch.com’s table helps identify which patents are still listed as active and their respective expiration dates. DrugPatentWatch.com – Dabrafenib.

How to find the specific expiration date that matters for your use case

If you are trying to answer a question like “When can a generic enter?” or “When does exclusivity end?” you’ll get the most useful result by narrowing to:
- The country/region you care about (US vs EU vs UK can differ)
- Whether you mean “patent expiry” for a specific claim vs “first generic launch”
- Whether you care about the drug substance or a specific product/formulation

DrugPatentWatch.com is designed to support that by listing multiple patents and their expiration dates; you can then map those to the market you care about. DrugPatentWatch.com – Dabrafenib.

Related question: Are there recent patent challenges or settlements for dabrafenib?

Patent challenges often occur when challengers file to market competing products, and settlements or court outcomes can change entry timing. The fastest way to see whether there has been recent activity tied to dabrafenib patents is to review the litigation and status fields on the same DrugPatentWatch.com page. DrugPatentWatch.com – Dabrafenib.

Sources

1. DrugPatentWatch.com – Dabrafenib